triiodothyronine has been researched along with 7432 s in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Inui, K; Ji, L; Masuda, S; Nishihara, K; Okuda, M; Shimizu, Y | 1 |
1 review(s) available for triiodothyronine and 7432 s
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for triiodothyronine and 7432 s
| Article | Year |
|---|---|
Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats.
Topics: Animals; Blotting, Western; Ceftibuten; Cephalosporins; Dipeptides; Disease Progression; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kidney; Male; Nephrectomy; Osmolar Concentration; Peptide Transporter 1; Rats; Rats, Wistar; Renal Insufficiency; RNA, Messenger; Symporters; Triiodothyronine | 2005 |